Similarly, repression of STEAP2 reversed the effect of EFEMP2 overexpression, and exogenous EFEMP2 activated the Akt pathway and EMT process in osteosarcoma cells but had no impact on cells with reduced STEAP2 or Akt expression. The gene discussed is STEAP2; the disease is osteosarcoma.